rosiglitazone has been researched along with Cancer of Stomach in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, LL; Chen, QY; Huang, CM; Huang, XB; Li, P; Lin, JX; Lin, M; Liu, LC; Lu, J; Tu, RH; Wang, HG; Wang, JB; Wang, LQ; Xie, JW; Zhao, YJ; Zheng, CH; Zhong, Q | 1 |
| Chen, FZ; Li, J; Mo, XM; Wang, QP; Zhang, L | 1 |
| Chang, SS; Hu, HY | 1 |
| Bae, YK; Cho, SJ; Choi, IJ; Kim, YW; Kook, MC; Lee, JH; Park, J; Ryu, KW; Shin, JY | 1 |
| Chen, BL; Cheng, YY; Chu, WK; Hu, PJ; Leung, WK; Sung, JJ; Wong, CY; Yu, J; Zeng, ZR | 1 |
| Hou, J; Lin, C; Ma, GD; Zhang, CQ; Zhang, LY | 1 |
| Hu, JF; Li, GQ; Su, Q; Xiao, X; Zhang, L | 1 |
| Bai, AH; Chan, FK; Chan, KK; Chan, MW; Chan, VY; Fu, YG; Leung, WK; Sung, JJ; To, KF; Wu, JR; Yu, J | 1 |
8 other study(ies) available for rosiglitazone and Cancer of Stomach
| Article | Year |
|---|---|
The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer.
Topics: Animals; Chromatin; Disease Models, Animal; Fatty Acid-Binding Proteins; Humans; Hypoglycemic Agents; Mice; PPAR gamma; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones | 2022 |
Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Nude; RNA, Messenger; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3 | 2013 |
Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case-control study.
Topics: Adult; Aged; Case-Control Studies; Comorbidity; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Population Surveillance; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones | 2013 |
Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Survival; Epithelial-Mesenchymal Transition; Galectins; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Transplantation; PPAR gamma; Prognosis; Promoter Regions, Genetic; Proportional Hazards Models; Protein Binding; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones; Up-Regulation; Zebrafish | 2015 |
Rosiglitazone suppresses gastric carcinogenesis by up-regulating HCaRG expression.
Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Down-Regulation; Gene Expression; Humans; Immunohistochemistry; Methylnitronitrosoguanidine; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Rats; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones; Up-Regulation | 2008 |
[Role of histone deacetylase in inhibiting invasion of human gastric carcinoma cell line SGC-7901 by PPARgamma-mediated pathway].
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Matrix Metalloproteinase 2; Neoplasm Invasiveness; PPAR gamma; RNA, Messenger; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones | 2009 |
Rosiglitazone reverses mitomycin C resistance in human gastric cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Humans; Hypoglycemic Agents; Inhibitor of Apoptosis Proteins; Mitomycin; Neoplasm Proteins; RNA, Messenger; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones | 2012 |
Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cyclooxygenase 2; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Isoenzymes; Ligands; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Nuclear Receptor Coactivators; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones; Transcription Factors; Tumor Cells, Cultured | 2004 |